A significant percentage of patients with Lyme arthritis and other Lyme disease manifestations were positive for anti-RA33 antibodies.
“The evidence behind the EULAR recommendation is obtained from studies in subgroups of patients using biological DMARDs or in subgroups of patients positive for anti-citrullinated protein ...